The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

clinDR: Simulation and Analysis Tools for Clinical Dose Response Modeling

Bayesian and ML Emax model fitting, graphics and simulation for clinical dose response. The summary data from the dose response meta-analyses in Thomas, Sweeney, and Somayaji (2014) <doi:10.1080/19466315.2014.924876> and Thomas and Roy (2016) <doi:10.1080/19466315.2016.1256229> Wu, Banerjee, Jin, Menon, Martin, and Heatherington(2017) <doi:10.1177/0962280216684528> are included in the package. The prior distributions for the Bayesian analyses default to the posterior predictive distributions derived from these references.

Version: 2.4.1
Depends: R (≥ 3.5.0), rstan (≥ 2.17.3), shiny
Imports: foreach, graphics, DoseFinding, stats, mvtnorm, utils, parallel, doParallel, ggplot2, tidyr, purrr, tibble, dplyr, glue, waiter
Published: 2023-08-09
DOI: 10.32614/CRAN.package.clinDR
Author: Neal Thomas ORCID iD [aut, cre], Jing Wu [aut], Mike K. Smith [aut]
Maintainer: Neal Thomas <snthomas99 at gmail.com>
License: GPL-2 | GPL-3 [expanded from: GPL (≥ 2)]
NeedsCompilation: no
Materials: NEWS
In views: Pharmacokinetics
CRAN checks: clinDR results

Documentation:

Reference manual: clinDR.pdf

Downloads:

Package source: clinDR_2.4.1.tar.gz
Windows binaries: r-devel: clinDR_2.4.1.zip, r-release: clinDR_2.4.1.zip, r-oldrel: clinDR_2.4.1.zip
macOS binaries: r-release (arm64): clinDR_2.4.1.tgz, r-oldrel (arm64): clinDR_2.4.1.tgz, r-release (x86_64): clinDR_2.4.1.tgz, r-oldrel (x86_64): clinDR_2.4.1.tgz
Old sources: clinDR archive

Reverse dependencies:

Reverse suggests: BayesianMCPMod

Linking:

Please use the canonical form https://CRAN.R-project.org/package=clinDR to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.